Monopar Therapeutics financial statements

모노파 테라퓨틱스NASDAQ:MNPR · Nasdaq · Healthcare · sector #16
$79.57+1.63%
2026-10-06 close · prelim

Monopar Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$16M.

Reported results

Monopar Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q